The recent challenges in global distribution have highlighted the importance of securing critical medications like Ivermectin. Dependence on overseas producers exposes countries to significant vulnerabilities, including delivery delays, cost fluctuations, and even political risks. Transitioning towards domestic production of Ivermectin offers a mul